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Ultraviolet Radiation Induces Both Full Activation of Ret
Kinase and Malignant Melanocytic Tumor Promotion in
RFP-RET-Transgenic Mice
To the Editor:
Iwamoto et al (1991) previously established three RET-onco-
gene-transgenic mouse lines (lines 192, 304, and 242) by
introducing RFP-RET, the 5¢ truncated c-RET proto-oncogene
fused to the 5¢ half of the RFP gene (Takahashi et al, 1985). In
all of the RFP-RET-transgenic mice of line 192, severe
systemic skin melanosis and benign melanocytic tumors
developed in the skin, but none of these tumors became
malignant during a 2 year period of observation after birth
(n=50) (Iwamoto et al, 1991; Kato et al, 1999). This line of
transgenic mice thereby provided a suitable animal mode for the
study on the potential UV radiation activity for malignant
melanocytic tumor promotion. Recently, we found that UV
irradiation to cells transfected with c-RET or mutant RET in
vitro induced not only activation of c-Ret but also second-step
activation (superactivation) of constitutively activated mutant
Ret (Kato et al, 2000). We report here that repeated UV
irradiation in situ to benign tumors in RFP-RET-transgenic
mice causes both full activation and development of malignant
melanomas.
We ®rst examined whether a single UV irradiation (FL20S.E-
30/DMR; spectral irradiance, 290±330 nm; peak wave, 305
nm; Toshiba Medical Supply, Tokyo, Japan) would modify the
activation and expression levels of the Rfp-Ret kinase proteins
in melanocytic tumors that had primarily developed in the
RFP-RET-transgenic mice. The UV dose for irradiation was
quanti®ed in J per m2 using a microvolt ampmeter (UVR-
3036/S; spectral sensitivities, 305 and 365 nm; Topcon, Tokyo,
Japan). Compared with the tumors after sham irradiation, single
UV (30 kJ per m2) irradiation to the tumors caused a 3±5-fold
increase in Rfp-Ret kinase activity for MBP phosphorylation
(Fig 1A), and a less marked (1.5±2-fold) increase in the Ret
protein expression (Fig 1C), at 48 h after irradiation. The UV-
mediated promotion of activation and expression of Rfp-Ret
accompanied increases in the expression (1.5±2-fold) and
phosphorylation (2±3-fold) levels of 42 kDa ERK (Fig 1E, G)
and c-Jun (Fig 2I, K ). Such levels of ERK/c-Jun responses did
not develop in the UV-irradiated non-transgenic control mice.
We next examined the effects of repeated UV irradiation on
the activation and expression levels of Rfp-Ret kinase proteins
and on the growth of melanocytic tumors in the RFP-RET-
transgenic mice. We applied UV irradiation (30±45 kJ per m2
per d) to the tumors ®ve times a week for 28 wk (total dose,
4950 kJ per m2). At more than 20 wk after the start of
irradiation, the originally slow-growing tumors started to grow
rapidly in all four of the irradiated mice but not in any of the
four unirradiated littermate control mice. Two of the four
irradiated mice died before extensive analyses were performed at
28 wk after the start of irradiation. In the growth-promoted
tumors in the mice that were still alive at 28 wk after the start
of irradiation, we found a striking (8±10-fold) increase in the
MBP phosphorylation level (Fig 1B) and a less marked but
clear (4±5-fold) increase in the Rfp-Ret protein expression level
(Fig 1D), accompanied by marked elevation in levels of protein
expression (4±5 times) and phosphorylation (8±10 times) of 42
kDa ERK (Fig 1F, H ) and c-Jun (Fig 1J, L). Histologically,
the benign melanocytic tumors had changed to malignant
melanomas in the two surviving irradiated mice (Fig 3B) but
not in the four unirradiated control mice (Fig 3A). Lung
metastasis was observed in one of the two mice with malignant
melanomas (data not shown). In addition, the same dose of UV
irradiation given to the tumor-free mice did not induce
development of either benign or malignant melanocytic tumors.
In both cases of single and repeated exposures of tumors to
UV, the increase in Rfp-Ret kinase activity was more
(approximately two times) extensive than expected from the
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Figure 1. UV irradiation in situ to melanocytic tumors caused full
activation of Rfp-Ret. Mice bearing benign melanocytic tumors of
almost the same size, taken from the same litter of RFP-RET-transgenic
mice of line 192, were randomly divided into UV irradiation (n=4) and
sham irradiation (control) groups (n=4). Tumors were irradiated with a
single dose of 30 kJ per m2 of UVB (A, C, E, G, I, K ) or with repeated
doses of a total of 4950 kJ per m2 of UV (B, D, F, H, J, L). The lysates of
these tumors were subjected to in vitro kinase assay (Kato et al, 1998) of the
Ret protein (A, B) and western blotting (Kato et al, 1998) with anti-Ret
(C, D), anti-ERK (E, F ), anti-phospho-ERK (G, H ), anti-c-Jun (I, J ), or
anti-phospho-c-Jun (K, L) antibodies. Lane 1, sham irradiation; lane 2,
single (A, C, E, G, I, K) or repeated (B, D, F, H, J, L) UV irradiation.
Representative data only are shown. p-Rfp-Ret, pMBP, pERK, and p-c-
Jun indicate phosphorylated proteins.
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increase in protein expression level. This suggested that UV
irradiation promotes both activation and expression levels of the
Rfp-Ret kinase. Rfp-Ret kinase is constitutively active due to
its oncogenic mutation (Takahashi et al, 1985). Thus, UV-
mediated superactivation of the mutant Ret kinase, which was
originally demonstrated in vitro (Kato et al, 2000), probably
occurred also in vivo. The signal triggered through super-
activation of Rfp-Ret kinase by UV might have promoted the
production of Rfp-Ret together with ERK and c-Jun, although
alternative mechanisms remain to be excluded. Whatever the
underlying mechanism is, our data suggest that UV-induced full
activation of a single oncogene and its product is included in
the mechanism of malignant melanocytic tumor promotion, in
addition to previously reported stepwise recruitment of multiple
oncogene activations (Ziegler et al, 1994) and defects in the
host defense mechanism (Kripke, 1979). This may stimulate
new experiments for fully understanding the general mechanism
of malignant tumor promotion following initiation.
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A Prospective Study of Incident Nonmelanoma Skin Cancer
in Heart Transplant Recipients
To the Editor:
The high incidence of nonmelanoma skin cancer (NMSC) in
transplant recipients is mainly due to immunosuppressive treatment
(EspanÄa et al, 1995; Bouwes-Bavinck et al, 1996; Jensen et al, 1999;
Ong et al, 1999). An increased exposure to ultraviolet radiation may
lead to an even higher risk (Kelly et al, 1987; Gallagher et al, 1995;
Krutman, 1997). We describe the incidence of NMSC in heart
transplant recipients (HTR) from a single Spanish center and assess
their main risk factors.
Out of 150 HTR between January 1984 and December 1997,
those who had a follow-up time superior to 6 mo after
transplantion (n = 124) were included in our assessment. Their
follow-up times were: >3 y, 80 patients; >5 y, 52 patients; >7 y, 27
patients; >9 y, 15 patients.
These selection criteria ensured that this series was comparable
with other reports (Couetil et al, 1990), including a previous shorter
Figure 2. Repeated UV irradiation induced the malignant tumor
promotion. Tissues of tumors from RFP-RET-transgenic mice of line 192
that had received sham irradiation (A) or repeated UV irradiation (B) were
stained with haematoxylin and eosin. (A) The tumor was composed of
round cells with round nuclei and low mitotic activity. (B) The tumor was
composed of atypical cells with various-sized nuclei and high mitotic
activity. Histologic properties of these benign and malignant tumors were
basically the same as those of the tumors we reported previously, which
spontaneously developed in the RFP-RET-transgenic mice of lines 304
Kato et al, 1998). Representative pictures only are shown. Scale bar: 15 mm.
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